VMRCVM
Search VMRCVM
DBSP
Roster  DBSP Departments VMRCVM

DBSP Faculty

Paul Christopher Roberts

Paul Christopher Roberts, Ph.D.

Associate Professor
Virology
Department of Biomedical Sciences & Pathobiology
 
e-mail: robec06@vt.edu
Capsule Biography (PDF)

 

Education

1992-1996 Postdoctoral, Microbiology/Virology
Emory University
Atlanta, GA
1992 Ph.D., Microbiology/Virology
Philipps-Universität Marburg
Marburg, Germany
1988 M.S., Microbiology
Philipps-Universität Marburg
Marburg, Germany
1984 B.S., Biology
Davidson College
Davidson, NC

Research Interests

For research project details, please see Dr. Roberts' laboratory research flyer.

  • Viral Vaccine Development
  • Host Pathogen Interactions and Viral:Bacterial Synergy in Disease Exacerbation
  • Immunotherapy and Virotherapy targeting Ovarian Cancer
     

Professional Experience

2007-present Associate Professor, Virology
Department of Biomedical Sciences and Pathobiology
Virginia-Maryland Regional College of Veterinary Medicine
Virginia Tech
Blacksburg, VA
1999-2007 Assistant Professor
Department of Immunology and Microbiology
Wayne State University School of Medicine
Detroit, MI
1996–1999 Senior Research Associate
Emory University School of Medicine
Atlanta, GA
1992-1996 Research Associate
Emory University School of Medicine
Atlanta, GA

Selected Honors & Awards

2006-Present Member, NIH Study Section ZRG1 IDM-10 “Bugs and Drugs”
2006 Member, DOD OC-1 Study Section, May
2005-2006 Member, NIH Study Section ZRG1 IDM-B
2003 Member, NIH Study Section VR-3, July
2006 Wayne State University, School of Medicine Teaching Award
2002 Wayne State University, School of Medicine Teaching Award

Professional Memberships

  • American Society of Virology
  • American Association of Cancer Research
  • American Society of Microbiology
     

Selected Publications

  • Andrew Herbert, Nicole Doyon-Reale, Roy S. Sundick and Paul C. Roberts. (2008). Membrane-bound Cytokines Augment Influenza Virus Vaccines and Protect Against Lethal Challenge in Mice. (submitted to J. Interferon and Cytokine Research)
  • Amouzegar, T. K. Trivedi, P.P, N.A. Wolf, P.C. Roberts, R. H. Swanborg. (2008). A Unique Subset of Bone Marrow-Derived Natural Killer Cells Regulates T Cell Activation. (J. Leukocyte Biology; in press)
  • Yufang Yang, David Legget, Andrew Herbert, Roy S. Sundick and Paul C. Roberts. (2008). A novel method to incorporate cytokines as adjuvants on the surface of whole, virus vaccines. (submitted to J. Interferon and Cytokine Research)
  • Janice Speshock, N. Doyon-Reale, R. Rabah, M. Neely and P.C. Roberts. (2007). Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae (serotype 3). Infection and Immunity 75 (6) 3102-3111.
  • Prachi P. Trivedi, Taba K. Amouzegar, Paul C. Roberts, Norbert A. Wolf, and Robert H. Swanborg. (2006). Regulation of Adaptive Immunity by cells of the the innate immune system: Bone marrow natural killer cells inhibit T cell proliferation. "Crossroads between Innate and Adaptive Immunity", Proceedings of the Aegean Conference, in Advances in Experimental Medicine and Biology, Springer Verlag.
  • Aviva Levine Fridman, L. Tang, O. I. Kulaeva, B. Y., Q. Li, P. C. Roberts, J. Abrams, M. A. Tainsky. (2006). Expression Profiling Identifies Three Pathways Altered in Cellular Immortalization: Interferon, Cell Cycle and Cytoskeleton., J Gerontol A Biol Sci Med Sci, 61 (9) 879-89.
  • Lin Tang, Paul C. Roberts, Janice M. Kraniak, Qunfang Li, , and Michael A. Tainsky. (2006). STAT1 expression is not sufficient to regulate interferon-signaling pathway in cellular immortalization. J Interferon and Cytokine Res. 26 (1) 14-26.
  • Roberts, P.C., Mottillo, E.P., Baxa, A., Reale, N., Gregoire, L., Rabah, R., Lancaster, W.D., and Schmelz, E.M. (2005) Sequential molecular and cellular events during neoplastic progression: a mouse syngeneic ovarian cancer model. Neoplasia 7 (10) 944-956.
  • Prachi P. Trivedi, Paul C. Roberts, Norbert A. Wolf, and Robert H. Swanborg. (2005). NK Cells Inhibit T Cell Proliferation via p21-Mediated Cell Cycle Arrest. J. Immunol. Volume 174 / No. 8/April 15th.